Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Non-cash Items (2023 - 2024)

Sagimet Biosciences has reported Non-cash Items over the past 2 years, most recently at $2.3 million for Q3 2024.

  • Quarterly results put Non-cash Items at $2.3 million for Q3 2024, up 29.7% from a year ago — trailing twelve months through Sep 2024 was $2.3 million (up 29.7% YoY), and the annual figure for FY2023 was $2.1 million, changed.
  • Non-cash Items for Q3 2024 was $2.3 million at Sagimet Biosciences, down from $2.6 million in the prior quarter.
  • Over the last five years, Non-cash Items for SGMT hit a ceiling of $2.6 million in Q2 2024 and a floor of $8000.0 in Q4 2023.